Audrey Y Frist

Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe.

Charles C Hong, Craig W Lindsley, C. Lindsley, 2013, Bioorganic & medicinal chemistry letters.